Polycystic ovary syndrome: A review for dermatologists Part I. Diagnosis and manifestations

被引:36
|
作者
Housman, Elizabeth [1 ]
Reynolds, Rachel V. [2 ]
机构
[1] Harvard Univ, Sch Med, Dept Internal Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Dermatol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
acanthosis nigricans; acne; anovulation; hirsutism; hyperandrogenism; insulin resistance; polycystic ovary syndrome; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DIABETES-MELLITUS; SYNDROME PCOS; RISK-FACTORS; WOMEN; PREVALENCE; HORMONE; HYPERANDROGENISM;
D O I
10.1016/j.jaad.2014.05.007
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Polycystic ovary syndrome (PCOS) is a common endocrine disorder among women who are of reproductive age. The pathogenesis involves several associated hormonal pathways that culminate in metabolic, reproductive, and cardiovascular effects. The hallmark features of hyperandrogenism and hyperinsulinemia have systemic long-term implications. Dermatologists frequently evaluate and manage the cutaneous manifestations of PCOS (ie, acanthosis nigricans, hirsutism, acne, and alopecia), and therefore play a key role in its diagnosis and management. In part I of this continuing medical education article, we review the definition, etiology, pathogenesis, and clinical features of PCOS.
引用
收藏
页码:847 / 858
页数:12
相关论文
共 50 条
  • [1] Polycystic ovary syndrome: A review for dermatologists Part II. Treatment
    Buzney, Elizabeth
    Sheu, Johanna
    Buzney, Catherine
    Reynolds, Rachel V.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 71 (05) : 859 - +
  • [2] Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
    Lowenstein, Eve J.
    DERMATOLOGIC THERAPY, 2006, 19 (04) : 210 - 223
  • [3] Dermatologic manifestations of polycystic ovary syndrome
    Lee, Amy T.
    Zane, Lee T.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2007, 8 (04) : 201 - 219
  • [4] Dermatologic Manifestations of Polycystic Ovary Syndrome
    Amy T. Lee
    Lee T. Zane
    American Journal of Clinical Dermatology, 2007, 8 : 201 - 219
  • [5] ACE I/D gene polymorphisms and polycystic ovary syndrome manifestations
    Asadi, Mojgan
    Klashami, Zeynab Nickhah
    Panahi, Nekoo
    Oheb, Yodit
    Khorasani, Sara
    Amoli, Mahsa M.
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2024, 23 (01) : 681 - 688
  • [6] Diagnosis and Treatment of Adolescent Polycystic Ovary syndrome:A Review
    Zhang, Yaoyang
    Yang, Kaiyu
    Fan, Ting
    Zheng, Dongying
    Liu, Hongxiu
    INTERNATIONAL JOURNAL OF WOMENS HEALTH, 2025, 17 : 459 - 474
  • [7] DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
    BAKER, ER
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (05): : 671 - 671
  • [8] Diagnosis of polycystic ovary syndrome
    Chang, RJ
    Katz, SE
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1999, 28 (02) : 397 - +
  • [9] Diagnosis of polycystic ovary syndrome
    Trivax, Bradley
    Azziz, Ricardo
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2007, 50 (01): : 168 - 177
  • [10] THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME
    Zivic, Sasa
    Cvetkovic, Vesna
    Stankovic, Sandra
    Vucic, Jelena
    Milojevic, Dejan
    PAEDIATRIA CROATICA, 2012, 56 : 1 - 8